IBBR awarded NIH grant to investigate T cell biology toward development of biotherapeutics

Published 1/31/19 by IBBR Findings may show how immune checkpoint LAG3 can be exploited to fight disease

William E. Bentley, Professor of Engineering and Founding Director of the Fischell Institute for Biomedical Devices joins Rich Bendis for the first BioTalk of 2019

Published on 1/21/19 on Biohealth Innovation